GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

69 hedge funds and large institutions have $35.5M invested in Galectin Therapeutics in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 11 closing their positions.

Holders
69
Holders Change
+7
Holders Change %
+11.29%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
19
Reduced
15
Closed
11
Calls
$1.17M
Puts
$3.83M
Net Calls
-$2.66M
Net Calls Change
-$2.74M

Top Buyers

1
BlackRock
1
BlackRock
New York
$3.74M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$2.28M
3
Group One Trading
3
Group One Trading
Illinois
$690K
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$480K
5
AG
5
Advisor Group
Arizona
$3.9M

Top Sellers

1
SM
1
Sabby Management
Florida
$89K
2
EI
2
EAM Investors
California
$1.39M
3
BCM
3
BlueCrest Capital Management
Jersey
$0
4
DADC
4
D.A. Davidson & Co
Montana
$4.18M
5
EGI
5
EAM Global Investors
California
$1.05M
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– -$6K -1,315 Closed
RAM
77
Riggs Asset Management
Pennsylvania
– -$5K -1,000 Closed
1 2 3
4